DA
Day One Bio
DAWN·NASDAQBrisbane CAFounded 2018200 employees
Mid CapbiotechPublicOncology
Platform: Pediatric Onc
Market Cap
$3B
All Drugs
3
Clinical Trials
5
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (DAWN)
Loading DAWN stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Nidasacituzumab | DAW-8338 | Phase 3 | 1 | TIGIT | Crohn'sOCD | ||
| DAW-5540 | DAW-5540 | Phase 2 | 2 | AHR | ALSGastric Ca | ||
| DAW-8159 | DAW-8159 | Phase 2 | 2 | PSMA | Dravet |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)